4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-22-060588
Co-Chief Executive Officer sold 1,255 shares at an average $5.28 ($6,621)
- Co-Chief Executive Officer acquired 3,167 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bernick Brian · Co-Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 1 in the form | +3,167 | 5,127 | D | ||
| 2022-12-06 | Sale : show line 2 in the form | −935 | $4.92 | $4,602 | 4,192 | D |
| 2022-12-09 | Sale : show line 3 in the form | −320 | $6.31 | $2,020 | 3,872 | D |
| Open-market sales · 1,255 sh · avg $5.28 · $6,621 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −3,167 | 10,517 | D |
Loading xslF345X03/doc4.xml…